MolMed Industry Symposium
Engineering Immune Effector Cells: a European Perspective
International Academy for Clinical Hematology (IACH) 2018
Saturday, September 29, 2018
13:15–14:15, Hall A
Paris Marriott Rive Gauche Hotel & Conference Center
Paris, France
| Symposium program |
| Suicide-gene donor T-cells: Zalmoxis clinical benefit in haploidentical stem cell transplantation Professor Fabio Ciceri Clinical Director of the Research Division of Regenerative Medicine, Cell and Gene Therapy and Director of the Hematology and Bone Marrow Transplantation Unit at San Raffaele Scientific Institute in Milano, Italy. |
| Optimized CD44v6 CAR-T cell therapeutics for Acute Myeloid Leukemia and Multiple Myeloma Monica Casucci Senior Post Doc Leukemia Immunotherapy Group, Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Hospital Scientific Institute, Milano, Italy. |
| CAR-T cells for myeloma: where do we stand? Professor Mohamad Mohty Head of the Hematology Department at the Saint-Antoine Hospital and University of Pierre and Marie Curie in Paris, France. |